pharma · Bioequivalence of Two Azilsartan Formulations
Lee's Pharmaceutical
Lee's Pharmaceutical Limited
Lee's Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Bioequivalence of Two Azilsartan Formulations. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Azilsartan (Zhaoke)
Phase 1 · small molecule · Bioequivalence of Two Azilsartan Formulations
Azilsartan (Zhaoke) for Bioequivalence of Two Azilsartan Formulations is a Phase 1 program (small_molecule) at Lee's Pharmaceutical Limited with 1 ClinicalTrials.gov record(s).
Internal code ZK-HK-AZI-201705
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lee's Pharmaceutical Limited
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Bioequivalence of Two Azilsartan Formulations
- Status
- completed
- Trials
- 1